Diabetic Foot Ulcer Treatment Market Size & Share, by Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-Ischemic Ulcer); Product (Wound-Care Dressings, Wound-Care Devices, Active Therapies); End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4603
Published Date: Mar 03, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Diabetic Foot Ulcer Treatment Landscape

UPM
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Orpyx Medical Technologies Inc.
PENTAX Medical
Smith & Nephew plc
Organogenesis Inc.
SIGVARIS GROUP
3M
Molnlycke Health Care AB,
Hill-Rom Holdings, Inc.
ConvaTec Inc.

Browse Key Market Insights with Data Illustration:

Diabetic Foot Ulcer Treatment Market Trends, Research Report 2023-2033

In the News

Orpyx Medical Technologies Inc. introduced Orpyx SI Sensory integrated with remote patient monitoring Insoles for preventing diabetic foot ulcers. It works by monitoring the temperature, pressure and movement and provide the user with real time audio-visual alarms, that enables them to take quicker decision for their health.
March 2022, chances of diabetes foot ulcers re-occur by half.

Frequently Asked Questions (FAQ)

An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 - 2033.

High cost associated with advanced diabetic foot ulcer treatment and patient management rules and regulations are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by ulcer type, product, end user and, by region.

The neuropathic ulcer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Diabetic Foot Ulcer Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the diabetic foot ulcer treatment market?

What would be the CAGR of diabetic foot ulcer treatment market over the forecast period?

What are the challenges affecting the diabetic foot ulcer treatment market growth?

Which region will provide more business opportunities for growth of diabetic foot ulcer treatment market in future?

Who are the major players dominating the diabetic foot ulcer treatment market?

How are the company profiles selected?

What are the segments in the diabetic foot ulcer treatment market?

Which segment captures the largest market size in ulcer type segment in the diabetic foot ulcer treatment market?